NCT03086681View on ClinicalTrials.gov

Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Cervical Carcinoma
Interventions
DRUG

Endostar

Endostar: 7.5mg/m2 d1-10, repeat every 15 days, for 4 cycles

DRUG

DDP

DDP: 40mg /m2，per week, for 5 cycles

Trial Locations (1)

530021

First Affiliated Hospital of Guangxi Medical University, Nanning

All Listed Sponsors
lead

Yong Zhang,MD

OTHER

NCT03086681 - Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma | Biotech Hunter | Biotech Hunter